Cdcl-010

To prevent address conflicts on the data bus, assign a unique hexadecimal ID.

If you need help with something else—such as understanding a technical term (like CDCL for a software algorithm or a different field), finding a product manual, or researching a different topic—feel free to provide more context, and I’ll be glad to assist. cdcl-010

CB-010 is an allogeneic, CRISPR-edited CAR-T cell therapy targeting CD19, featuring a PD-1 knockout to enhance effectiveness in treating relapsed/refractory B-cell non-Hodgkin lymphoma [11, 16]. Data from the ANTLER Phase 1 trial presented at the 2024 ASCO Annual Meeting reported a 94% overall response rate, demonstrating a manageable safety profile [16]. Detailed study findings are available in the ASH Publications Blood Journal [11]. AI can make mistakes, so double-check responses Copy Creating a public link... You can now share this thread with others Good response Bad response Show all To prevent address conflicts on the data bus,